Guidelines on Testicular Cancer: 2015 Update

Peter Albers, Walter Albrecht, Ferrán Algaba, +7

European Urology

AndrologySurgical OncologyUrologyGenitourinary CancerTesticular Cancer +5

Talazoparib plus enzalutamide in men with first-line metastatic castration-resistant prostate cancer (TALAPRO-2): a randomised, placebo-controlled, phase 3 trial

Neeraj Agarwal, Arun Azad, Joan Carles, +18

The Lancet

UrologyMedicinePharmacologyClinical TrialsPharmacotherapy +3

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

Michiel S. van der Heijden, Guru Sonpavde, Thomas Powles, +21

New England Journal of Medicine

Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

J. Beyer, Peter Albers, Renske Altena, +56

Annals of Oncology

ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

Friedemann Honecker, Jorge Aparicio, Daniel M. Berney, +33

Annals of Oncology

Long-Term and Late Effects of Germ Cell Testicular Cancer Treatment and Implications for Follow-Up

Hege Sagstuen Haugnes, George J. Bosl, Hink Boer, +6

Journal of Clinical Oncology

Surgical OncologyLate EffectsCancer ManagementGynecologyVarious Adverse Effects +16

Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up

Jan Oldenburg, Daniel M. Berney, Carsten Bokemeyer, +10

Annals of Oncology

InfertilityUrologyAndrologyGynecologyTesticular Seminoma +2

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

J. Alfred Witjes, Marek Babjuk, Joaquim Bellmunt, +117

European Urology

EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

Alan Horwich, Marek Babjuk, Joaquim Bellmunt, +118

Annals of Oncology

UrologyGenitourinary CancerEau–esmo Consensus StatementsMedicineCancer Management +5

One course of adjuvant BEP in clinical stage I nonseminoma mature and expanded results from the SWENOTECA group

Torgrim Tandstad, O. Ståhl, Ulf Håkansson, +13

Annals of Oncology

Clinical StageMedicineImmunodeficienciesClinical TrialsPathology +3